About Us  |  Contact Us  |  Español
VNA of Care New England
VNA of Care New England

FDA: Fluoroquinolones May Cause Irreversible Nerve Damage

Risk applies only to those taken by mouth or injection
FRIDAY, Aug. 16 (HealthDay News) -- Fluoroquinolone antibacterial drugs may cause permanent nerve damage; the U.S. Food and Drug Administration is requiring updated drug labels and medication guides to reflect this fact, according to a Drug Safety Communication issued by the agency.
The side effect of peripheral neuropathy is a risk associated only with those fluoroquinolones taken orally or by injection; there is no known risk associated with formulations applied topically to eyes or ears.
Approved fluoroquinolone drugs include levofloxacin (Levaquin), ciprofloxacin (Cipro), moxifloxacin (Avelox), norfloxacin (Noroxin), ofloxacin (Floxin), and gemifloxacin (Factive).
The FDA advises physicians to: "Make sure your patients know to contact you if they develop symptoms of peripheral neuropathy. Make sure your patients receive the Medication Guide with every prescription. If a patient develops symptoms of peripheral neuropathy, the fluoroquinolone should be stopped, and the patient should be switched to another, non-fluoroquinolone antibacterial drug, unless the benefit of continued treatment with a fluoroquinolone outweighs the risk."
More Information (http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm365302.htm?source=govdelivery )
Health Headlines
Most Medical Devices Approved for Kids Only Tested on Adults: StudyView in a lightbox
FDA Approves Under-the-Tongue Hay Fever PillView in a lightbox
Salmonella Cases Dip in U.S., But Food Poisoning Rates Remain HighView in a lightbox
Misdiagnoses Common Among U.S. Outpatients: ReviewView in a lightbox
Off Season May Not Be Long Enough to Recover From Football 'Hits'View in a lightbox
VNA of Care New England
© 2011 Site Index | Disclaimer | Legal Notices